Assay for detecting human papilloma virus (HPV)
US12018328B2 · kind B2 · utility
0Cited by
6References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 7, 2022 |
| Grant date | Jun 25, 2024 |
| Priority date | — |
| Expiry date | Dec 7, 2042 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/025
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The disclosure is directed to kits and methods for amplifying and detecting human papilloma virus (HPV) of genotype 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, and/or 68 in a sample, which comprises a variety of combinations of forward oligonucleotide primers, reverse oligonucleotide primers, and oligonucleotide probes.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.